Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 119 publications
Radiation Therapy for Pancreatic Cancer: An ASTRO Clinical Practice Guideline.
Journal: Practical radiation oncology
Published: March 25, 2026
Quantitative benefit-risk assessment of data from the phase III ClarIDHy study of ivosidenib versus placebo in patients with mIDH1 cholangiocarcinoma.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Genomic analysis of oesophageal carcinoma (EC) identifies recurrent mutations in histone methyltransferases as a distinctive subset.
Journal: Oncogene
Published: November 05, 2025
ACR Appropriateness Criteria® Staging and Follow-Up of Primary Liver Cancer.
Journal: Journal of the American College of Radiology : JACR
Published: August 22, 2025
Spatial Biology and Organoid Technologies Reveal a Potential Therapy-Resistant Cancer Stem Cell Population in Pancreatic Ductal Adenocarcinoma.
Journal: bioRxiv : the preprint server for biology
Published: July 15, 2025
Intrahepatic cholangiocarcinoma: Insights on molecular testing, targeted therapies, and future directions from a multidisciplinary panel.
Journal: Hepatology communications
Published: March 17, 2025
KRAS G12D -Specific Targeting with Engineered Exosomes Reprograms the Immune Microenvironment to Enable Efficacy of Immune Checkpoint Therapy in PDAC Patients.
Journal: medRxiv : the preprint server for health sciences
Published: March 17, 2025
Anti-PD-1 Therapy for Patients with Advanced Cholangiocarcinoma: Ready for Prime Time?
Journal: Journal of immunotherapy and precision oncology
Published: February 12, 2025
Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 15, 2025
Last Updated: 09/26/2026